glp-1 weight loss type 1 diabetes on a Drug? Watch for Hypoglycemia and DKA How Effective and Safe Are

The massive weight-loss numbers you see in commercials, 15% to 20% body-weight loss, come from high therapeutic doses in controlled clinical trials

The Average GLP-1 User Saves $500 Annually The average out-of-pocket cost for GLP-1 drugs among respondents is $176 per month

L., West, A

Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

FA: Writing original draft

But the specifics depend on your formulation type